{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:48:09Z","timestamp":1780098489754,"version":"3.54.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.psyneuen.2019.104414","type":"journal-article","created":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T10:37:44Z","timestamp":1566643064000},"page":"104414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["S100 calcium-binding protein B in older patients with depression treated with electroconvulsive therapy"],"prefix":"10.1016","volume":"110","author":[{"given":"Angela","family":"Carlier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Boers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Veerhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Bouckaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Sienaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"Eikelenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Vandenbulcke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max L.","family":"Stek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"van Exel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemiek","family":"Dols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didi","family":"Rhebergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2019.104414_bib0005","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1136\/jnnp.71.3.394","article-title":"Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100","volume":"71","author":"Agelink","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106342","article-title":"Systematic review and meta-Analysis of circulating S100B blood levels in schizophrenia","volume":"9","author":"Aleksovska","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0015","series-title":"Practical Statistics for Medical Research. Designing Research","author":"Altman","year":"1991"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0020","first-page":"1","article-title":"S100B serum levels predict treatment response in patients with melancholic depression","volume":"19","author":"Ambr\u00e9e","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0025","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association, A.P.A","year":"2000"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0924-977X(03)00016-6","article-title":"S100B and response to treatment in major depression: a pilot study","volume":"13","author":"Arolt","year":"2003","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0035","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/01.yct.0000235925.37494.2c","article-title":"S100 and impact of ECT on depression and cognition","volume":"22","author":"Arts","year":"2006","journal-title":"J. ECT"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neulet.2003.09.062","article-title":"Target evaluation processing and serum levels of nerve tissue protein S100B in patients with remitted major depression","volume":"354","author":"Dietrich","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0045","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jagp.2016.09.005","article-title":"Early- and late-onset depression in late life: a prospective study on clinical and structural brain characteristics and response to electroconvulsive therapy","volume":"25","author":"Dols","year":"2016","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/156652413804486214","article-title":"Functions of S100 proteins","volume":"13","author":"Donato","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0055","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bbamcr.2008.11.009","article-title":"S100B\u2019s double life: intracellular regulator and extracellular signal","volume":"1793","author":"Donato","year":"2009","journal-title":"Biochim. Biophys. Acta - Mol. Cell Res."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jpsychires.2014.12.002","article-title":"S100B blood levels and childhood trauma in adolescent inpatients","volume":"62","author":"Falcone","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0065","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1515\/CCLM.2010.262","article-title":"S100B protein increases in human blood and urine during stressful activity","volume":"48","author":"Gazzolo","year":"2010","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0070","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/JCP.0b013e3181ee0f5f","article-title":"Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis","volume":"30","author":"Heijnen","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00213-004-1999-z","article-title":"The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment","volume":"178","author":"Hetzel","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0080","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00702-008-0041-8","article-title":"Serum levels of S100B are decreased in chronic starvation and normalize with weight gain","volume":"115","author":"Holtkamp","year":"2008","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0085","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.psyneuen.2018.12.233","article-title":"Microglial-driven changes in synaptic plasticity: A possible role in major depressive disorder","volume":"102","author":"Innes","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4306\/pi.2008.5.3.193","article-title":"Serum S100B levels and major depressive disorder: its characteristics and role in antidepressant response","volume":"5","author":"Jang","year":"2008","journal-title":"Psychiatry Invest."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0095","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/cncr.11409","article-title":"Serum S100\u03b2: a noninvasive marker of blood-brain barrier function and brain lesions","volume":"97","author":"Kanner","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0100","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1089\/neu.2006.23.1185","article-title":"A critical analysis of the role of the neurotrophic protein S100B in acute brain injury","volume":"23","author":"Kleindienst","year":"2006","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0105","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00701-013-1720-2","article-title":"Intraperitoneal treatment with S100B enhances hippocampal neurogenesis in juvenile mice and after experimental brain injury","volume":"155","author":"Kleindienst","year":"2013","journal-title":"Acta Neurochir. (Wien)"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0110","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1089\/neu.2005.22.645","article-title":"Enhanced hippocampal neurogenesis by intraventricular S100B infusion is associated with improved cognitive recovery after traumatic brain injury","volume":"22","author":"Kleindienst","year":"2005","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/801295","article-title":"The passage of S100B from brain to blood is not specifically related to the blood-brain barrier integrity","volume":"2010","author":"Kleindienst","year":"2010","journal-title":"Cardiovasc. Psychiatry Neurol."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0120","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00702-014-1228-9","article-title":"Protein S-100 and neuron-specific enolase serum levels remain unaffected by electroconvulsive therapy in patients with depression","volume":"121","author":"Kranaster","year":"2014","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0125","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/08039488.2018.1472295","article-title":"Does S100B have a potential role in affective disorders? A literature review","volume":"72","author":"Kroksmark","year":"2018","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0130","doi-asserted-by":"crossref","first-page":"198s","DOI":"10.1016\/S0924-9338(99)80239-9","article-title":"The mini international neuropsychiatric interview","volume":"13","author":"Lecrubier","year":"1998","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0135","first-page":"3","article-title":"The increasing burden of depression","volume":"7","author":"L\u00e9pine","year":"2011","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.psyneuen.2016.11.031","article-title":"Oxidative stress, inflammation and treatment response in major depression","volume":"76","author":"Lindqvist","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/2358451","article-title":"S100B, homocysteine, vitamin B12, folic acid, and procalcitonin serum levels in remitters to electroconvulsive therapy: a pilot study","author":"Maier","year":"2018","journal-title":"Dis. Markers"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0150","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0165-0327(02)00044-7","article-title":"Glia as a putative target for antidepressant treatments","volume":"75","author":"Manev","year":"2003","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0155","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/sj.mp.4000811","article-title":"Neuroplasticity and cellular resilience in mood disorders","volume":"5","author":"Manji","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0160","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/jnc.14574","article-title":"The S100B story: from biomarker to active factor in neural injury","volume":"148","author":"Michetti","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0165","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.psychres.2009.01.027","article-title":"Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: serum levels of neuron-specific enolase and S-100b protein","volume":"177","author":"Palmio","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0175","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.npp.1301574","article-title":"Stress, depression, and neuroplasticity: a convergence of mechanisms","volume":"33","author":"Pittenger","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0180","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1176\/ajp.153.8.985","article-title":"Resistance to antidepressant medications and short-term clinical response to ECT","volume":"153","author":"Prudic","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0185","doi-asserted-by":"crossref","first-page":"849","DOI":"10.12740\/PP\/62393","article-title":"The role of S100B protein as a potential marker in affective disorder","volume":"50","author":"Rajewska-Rager","year":"2016","journal-title":"Psychiatr. Pol."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0190","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/jnr.20584","article-title":"S100B counteracts effects of the neurotoxicant trimethyltin on astrocytes and microglia","volume":"81","author":"Reali","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpsychires.2016.08.004","article-title":"Increased BDNF levels after electroconvulsive therapy in patients with major depressive disorder: a meta-analysis study","volume":"83","author":"Rocha","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0200","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.pnpbp.2006.09.013","article-title":"Glial cell activation in a subgroup of patients with schizophrenia indicated by increased S100B serum concentrations and elevated myo-inositol","volume":"31","author":"Rothermundt","year":"2007","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0205","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0210","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.brainres.2004.01.028","article-title":"Relationship between stress and circulating levels of S100B protein","volume":"1004","author":"Scaccianoce","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0215","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2174\/13894501113149990014","article-title":"Serum S100B represents a new biomarker for mood disorders","volume":"14","author":"Schroeter","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0220","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/00001756-200209160-00021","article-title":"S100B is increased in mood disorders and may be reduced by antidepressive treatment","volume":"13","author":"Schroeter","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0225","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jad.2008.03.005","article-title":"Serum markers support disease-specific glial pathology in major depression","volume":"111","author":"Schroeter","year":"2008","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0230","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/mp.2008.85","article-title":"Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders","volume":"14","author":"Schroeter","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0235","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.psyneuen.2009.07.012","article-title":"S100B serum levels are closely correlated with body mass index: an important caveat in neuropsychiatric research","volume":"35","author":"Steiner","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0240","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","article-title":"Inflammation and clinical response to treatment in depression: a meta-analysis","volume":"25","author":"Strawbridge","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0245","first-page":"1","article-title":"Salivary cortisol as predictor for depression characteristics and remission in electroconvulsive therapy in older persons","author":"Suijk","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0250","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00701-016-3046-3","article-title":"A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury","volume":"159","author":"Thelin","year":"2017","journal-title":"Acta Neurochir. (Wien)"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0255","series-title":"Guideline Electroconvulsive Therapy [Richtlijn elektroconvulsietherapie]","author":"van den Broek","year":"2010"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0260","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/cc1521","article-title":"Statistics review 4: sample size calculations","volume":"6","author":"Whitley","year":"2002","journal-title":"Crit. Care"},{"key":"10.1016\/j.psyneuen.2019.104414_bib0265","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s00702-008-0130-8","article-title":"The effects of gender and numbers of depressive episodes on serum S100B levels in patients with major depression","volume":"115","author":"Yang","year":"2008","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.psyneuen.2019.104414_bib0270","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000219304","article-title":"S100B serum levels and word memory processing in remitted major depression as reflected by brain potentials","volume":"59","author":"Zhang","year":"2009","journal-title":"Neuropsychobiology"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453019304172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453019304172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T17:06:30Z","timestamp":1759683990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453019304172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":54,"alternative-id":["S0306453019304172"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104414","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S100 calcium-binding protein B in older patients with depression treated with electroconvulsive therapy","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104414"}}